In 2022, we generated EUR 281 million in revenue, and our active custom projects pipeline included 220 projects at the end of the year. The structure of revenue and the active custom projects pipeline provide insights into our activities and the innovation efforts of our customers.
Helping patients across multiple health indications
Approx. revenue split by therapeutic areas (as per 31 December 2022)
Metabolic
Gastrologic
Oncologic
Cardio- and neurologic
Coronavirus pandemic related
Other
Servicing a diversified customer base
Approx. revenue split by customer type (as per 31 December 2022)
Large pharma
Biotech
Other pharma & academia
Solutions for development and commercial products
Revenue by business area (as per 31 December 2022)
Custom Projects
Contract Manufacturing
Generetic & Cosmetics
“Start here – stay here”
Number of active custom projects (as per 31 December 2022)
Pre-clinical
Phase I
Phase II
Phase III